Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence.
Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, Pain Treatment & CNS, and Late Phase & RWE.
-
Secteur
-
Fabrication de produits pharmaceutiques
-
Taille de l’entreprise
-
501-1 000 employés
-
Siège social
-
Boulogne-Billancourt, Île-de-France
-
Type
-
Société civile/Société commerciale/Autres types de sociétés
-
Fondée en
-
2014
-
Domaines
-
Opérations cliniques, Affaires Réglementaires, Biométrie, Rédaction Médicale, Pharmacoviglance, Information Médicale, Contract Research Organisation, Biometrics and Clinical Research, Data Management, Pharmacovigilance, Medical Affairs, Biotech, Medical Devices, Clinical Trials, Drug Development Services, Oncology, Market Access, Rare Disease, Pharmaceuticals, CRO, Clinical Trial Optimization, Cell and Gene Therapy, Infectious Diseases, Immuno-Oncology, Cosmetics et Nutrition